• Takeda receives Ministry approval for depression drug biospectrumasia
    September 23, 2019
    Vortioxetine is already approved in 83 countries, including US, Europe, Canada, Chile, China, Mexico, Argentina, South Korea, Turkey, Australia, Hong Kong, S.A.R., China, Singapore and South Africa.
PharmaSources Customer Service